GlassScriptPhysician profile
Annamaria Nagy
NPI 1043321904
$750.93
in general payments reported to CMS, 2019-2025
15 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.44 · 2020: $11.91 · 2021: $146 · 2022: $98.97 · 2023: $183 · 2024: $89.48 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368 · Education: $61.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.54 |
| Education | $61.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $124.69 | 2023-2025 | Myfembree, Gemtesa |
| E.R. Squibb & Sons, L.L.C. | $117.13 | 2021 | |
| Astellas Pharma US INC | $109.21 | 2023-2025 | Veozah |
| Pfizer INC. | $96.49 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $88.98 | 2023-2025 | |
| Abbvie INC. | $39.96 | 2019-2022 | |
| Myovant Sciences INC. | $39.24 | 2022 | |
| Exeltis, USA INC. | $29.65 | 2023 | Slynd, Tyblume |
| Vertex Pharmaceuticals Incorporated | $23.58 | 2025 | |
| Amag Pharmaceuticals, INC. | $16.37 | 2019 | |
| Duchesnay USA Incorporated | $14.36 | 2019 | |
| Allergan, INC. | $13.28 | 2019 | |
| Coopersurgical, INC. | $13.27 | 2024 | Paragard T 380a |
| Amgen INC. | $12.81 | 2023 | Prolia, Evenity |
| Therapeuticsmd, INC. | $11.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annamaria Nagy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.